Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis

被引:641
|
作者
Tiniakos, Dina G. [1 ]
Vos, Miriam B. [2 ]
Brunt, Elizabeth M. [3 ]
机构
[1] Univ Athens, Lab Histol & Embryol, Sch Med, Athens 11527, Greece
[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
hepatic steatosis; liver disease; MALLORY-DENK BODIES; NF-KAPPA-B; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; ADIPOSE-TISSUE; VISCERAL FAT; TNF-ALPHA; TRIGLYCERIDE SYNTHESIS; MOLECULAR-MECHANISMS;
D O I
10.1146/annurev-pathol-121808-102132
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nonalcoholic fatty liver disease (NNFLD) is recognized as the leading cause of chronic liver disease in adults and children. NTAFLD encompasses a spectrum of liver injuries ranging from steatosis to steatohepatitis with or without fibrosis. Fibrosis may progress to cirrhosis and complications including hepatocellular carcinoma. Histologic findings represent the complexity of pathophysiology. NNFLD is closely associated with obesity and is most closely linked with insulin resistance; the current Western diet, high in saturated fats and fructose, plays a significant role. There are several mechanisms by which excess triglycerides are acquired and accumulate in hepatocytes. Formation of steatotic droplets maybe disordered in NAFLD. Visceral adipose tissue dysfunction in obesity and insulin resistance results in aberrant cytokine expression; many cytokines have a role in liver injury in NAFLD. Cellular stress and immune reactions, as well as the endocannabinoid system, have been implicated in animal models and in some human studeis.
引用
收藏
页码:145 / 171
页数:27
相关论文
共 50 条
  • [1] Pathology of nonalcoholic fatty liver disease
    Tiniakos, D. G.
    Kittas, Ch
    [J]. ANNALS OF GASTROENTEROLOGY, 2005, 18 (02): : 148 - 159
  • [2] Pathology of nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (04) : 195 - 203
  • [3] Pathology of nonalcoholic fatty liver disease
    Yeh, Matthew M.
    Brunt, Elizabeth M.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (05) : 837 - 847
  • [4] Pathology of nonalcoholic fatty liver disease
    Elizabeth M. Brunt
    [J]. Nature Reviews Gastroenterology & Hepatology, 2010, 7 : 195 - 203
  • [5] Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
    Pickett-Blakely, Octavia
    Young, Kimberly
    Carr, Rotonya M.
    [J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2018, 6 (04): : 451 - 462
  • [6] MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
    Fang, Zhiqiang
    Dou, Guorui
    Wang, Lin
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (07): : 1851 - 1863
  • [7] Pathogenesis of nonalcoholic fatty liver disease (NAFLD)
    Farrell, Geoffrey C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A30 - A30
  • [8] Pathogenesis of primary nonalcoholic fatty liver disease
    Sánchez, DM
    [J]. MEDICINA CLINICA, 2005, 124 (17): : 668 - 677
  • [9] Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
    Arun J Sanyal
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 46 - 53
  • [10] Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease
    Sanyal, AJ
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (01): : 46 - 53